期刊文献+

草酸铂联合5-氟脲嘧啶与甲酰四氢叶酸治疗晚期大肠癌临床观察 被引量:3

A Clinical Study of Oxaliplatin Plus 5-FU/cf in Treatment of Advanced Colorectal Cancer
下载PDF
导出
摘要 目的 观察草酸铂联合化疗治疗晚期大肠癌临床疗效。方法  3 2例晚期大肠癌患者 ,用草酸铂 13 0mg/m2 ,静脉滴注 2小时 ,化疗d1,甲酰四氢叶酸 10 0mg/m2 化疗d1~ 5 ;5 氟脲嘧啶 0 .5g静脉滴注化疗d1~ 5 ,每 3周重复一次 ,治疗 2周期后评定疗效 ,有效病例 4周期后确认疗效。结果  3 2例中CR 3例 ,PR 11例 ,SD 14例 ,PD 4例 ,总有效率 (CR +PR) 43 .8%。主要毒副作用 :Ⅰ~Ⅱ度恶心、呕吐 ,腹泻 ,感觉神经毒性 ,黏膜炎 ,骨髓抑制 ,静脉炎等。结论 草酸铂联合 5 FU +CF治疗晚期大肠癌效果良好 ,不良反应可耐受 ,值得临床推广。 Objective To evaluate the clinical efficacy and toxicity of Oxaliplatin plus 5-FU/CF combination in advanced colorectal cancer. Methods Thirty-two patients with advanced colorectal cancer were treated with Oxaliplatin plus 5-FU/CF. Oxaliplatin 130 mg/m 2 in infusion for two hours , in the first day and cf 100mg/m 2 in infusion ,from the first day to the fifth day ,and 5-FU 0.5g/m 2 in infusion, from the first day to the fifth day. The above-mentioned regimen was repeated every three weeks . The curative effect was evaluated two weeks later, and the response for the effective patients were confirmed four weeks later. Results Among the total 32 cases, there were CR 3,PR 11, SD 14, PD 4, with an overall response rate (CR+PR) of 43.8%. The main adverse effects were nausea and vomiting , diarrhea, neurousensory ,toxicity , mucositis, neutropenia and peripheral phlebitis. Conclusion Oxaliplatin is safe and effective in treating advanced colorectal cancer.The effect of 5-FU/CF is enhanced significantly when Oxaliplatin is combined. The toxicity is mild and tolerable for most of the patients.
出处 《河南肿瘤学杂志》 2004年第1期37-38,共2页 Henan Journal of Oncology
关键词 草酸铂 联合用药 5-氟脲嘧啶 甲酰四氢叶酸 药物治疗 晚期大肠癌 静脉滴注 combination chemotherapy colorectal cancer oxaliplatin 5-fluorouracil leucovorin
  • 相关文献

参考文献2

  • 1Seymour MT,Stenning SP,Cassidy J. Attitudes and pratice in the management of metastatic colorectal cancer in Britain .Colorectal cancer working party of the UK medical research council [J]. Clin Oncol, 1997,9(4):248-251.
  • 2林英城,林雯,林懿.晚期大肠癌化学治疗进展[J].国外医学(肿瘤学分册),2002,29(5):393-396. 被引量:12

二级参考文献27

  • 1Carmichael J,Popiela T,Radstone D,et al.Randomized comparative study of ORZEL(R)(oral uracil/tegafur(UFTTM) plus leucovorin(LV))versus parenteral 5-fluorouracil(5-FU)plus LV in patients with metastatic colorectal cancer[J].Proc Am Soc Clin On col,1999,18:264a.
  • 2Van Cutsem E,Sorensen J,Cassidy J,et al.International phase Ⅲ study of oral eniluracil(EU)plus 5-fluorouracil(5-FU)versus intravenous(IV)5-FU plus leucovorin(LV)in the treatment of advanced colorectal cancer(ACC)[J].Proc Am Soc Clin Oncol,2001,20:131a.
  • 3Levin J,Schilsky R,Burris H,et al.North American phase Ⅲ study of oral eniluracil(EU)plus oral 5-fluorouracil(5-FU)versus intravenous(IV)5-FU plus lencovorin(LV)in the treatment of advanced colorectal cancer(ACC)[J].Proc Am Soc Clin Oncol,2001,20:132a.
  • 4Hoff PM,Ausari R,Batist G,et al.Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer:results of a randomized phase Ⅲ study[J].J Clin Oncol,2001,19(8):2282-2292.
  • 5Van Cutsem E,Twelves C,Cassidy J,et al.Oral capecitabine compared with intravenous fluorouracil plus teucovorin in patients with metastatic colorectal cancer:results of a large phase Ⅲ study[J].J Clin Oncol,2001,19(21):4097-4106.
  • 6Meta-Analysis Group in Cancer:Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal eancer[J].J Natl Cancer Inst,1996,88(5):252-258.
  • 7McArdle C,Kerr DJ,Ledermann J,et al.Intravenous(IV)vsintrahepatic arterial(IHA)5-FU/lencovorin for colorectal(CRC)liver metastasis:preliminary results of the mre ero5/eortc 40972 randomized trial[J].Eur J Cancer,2001,37(Suppl 6):257.
  • 8Knight RD,Miller LL,Pirotta N,et al.First-line irinotecan(C),fluorouracil(F),leucovorin(L)especially improves survival(OS) in metastatic colorectal cancer(MCRC)patients(PT)with favorable prognostic indicators[J].Proc Am Soc Clin Oncol,2000,19:255a.
  • 9Maasacesi C,Norman A,Price T,et al.A clinical nomogram for predicting long-term survival in advanced colorectal eancer[J].Eur J Cancer,2000,36(16):2044-2052.
  • 10Bensmaine MA,Marty M,de Gramont A,et al.Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil(5-FU)+/-folinic acid in a compassionate-use cihort of 481 5-FU-resistant advanced colorectal cancer patients[J].Br J Cancer,2001,85(4):509-517.

共引文献11

同被引文献7

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部